Unnamed: 0,title,date,stock,sentiment
1395492.0,"The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection",2020-03-19 07:37:00-04:00,XTLB,neutral
1395493.0,"The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates",2020-03-18 07:36:00-04:00,XTLB,positive
1395494.0,"The Daily Biotech Pulse: Roche Obtains FDA Emergency Use Authorization For COVID-19 Test, Chembio Appoints New CEO, Inovio Slumps On Earnings",2020-03-13 07:52:00-04:00,XTLB,negative
1395495.0,"The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO",2020-03-12 07:37:00-04:00,XTLB,negative
1395496.0,Stocks That Hit 52-Week Lows On Wednesday,2020-03-11 11:41:00-04:00,XTLB,negative
1395497.0,"The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 Treatment",2020-03-11 08:03:00-04:00,XTLB,positive
1395498.0,Stocks That Hit 52-Week Lows On Tuesday,2020-03-10 10:37:00-04:00,XTLB,negative
1395499.0,"The Daily Biotech Pulse: Mesoblast To Test Candidate On Coronavirus Symptoms, Proxy Battle Ahead For Rockwell Medical, Glaukos to Join S&P SmallCap 600 Index",2020-03-10 09:19:00-04:00,XTLB,negative
1395500.0,146 Biotechnology Stocks Moving In Thursday's Session,2020-01-23 12:47:00-05:00,XTLB,neutral
1395501.0,98 Biotechnology Stocks Moving In Wednesday's Session,2020-01-22 13:33:00-05:00,XTLB,neutral
1395502.0,116 Healthcare Stocks Moving In Wednesday's Session,2020-01-22 12:37:00-05:00,XTLB,neutral
1395503.0,"The Daily Biotech Pulse: Aurinia Rips Higher On Positive Readout, Sesen Bio On Track For Vicinium BLA Submission",2019-12-05 07:14:00-05:00,XTLB,positive
1395504.0,"The Daily Biotech Pulse: Patent Win For Cellectis, Hepion Proves Efficacy In Animal Model, Job Cuts At Neon",2019-11-21 07:22:00-05:00,XTLB,positive
1395505.0,"The Daily Biotech Pulse: Amarin Gets Unanimous Backing For Vascepa Expansion, BeiGene's Blood Cancer Drug Gets Approval",2019-11-15 07:08:00-05:00,XTLB,negative
1395506.0,"The Daily Biotech Pulse: Merck Goes Shopping, Nuvectra Files For Bankruptcy Protection, Opiant Rips Higher",2019-11-13 07:10:00-05:00,XTLB,neutral
1395507.0,"The Daily Biotech Pulse: Reata, Kadmon Clinical Readouts, Apyx Medical's Earnings Beat",2019-11-12 07:20:00-05:00,XTLB,neutral
1395508.0,"The Daily Biotech Pulse: Biogen Alzheimer's Program Back On Track, Novartis Reports Strong Quarter, Takeda In-Licenses Autoimmune Disorder Drug",2019-10-22 07:51:00-04:00,XTLB,positive
1395509.0,"The Daily Biotech Pulse: J&J Settles Ohio Opioid Lawsuit, Teligent Explores Options For Certain Assets, Novartis Reports Cosentyx Data",2019-10-02 07:17:00-04:00,XTLB,positive
1395510.0,"The Daily Biotech Pulse: ESMO Conference Gets Underway, J&J's Darzalex Snags Another Approval, Kaleido Biosciences CFO To Leave",2019-09-27 07:56:00-04:00,XTLB,positive
1395511.0,71 Biggest Movers From Yesterday,2019-03-06 04:57:00-05:00,XTLB,neutral
1395512.0,56 Stocks Moving In Tuesday's Mid-Day Session,2019-03-05 12:36:00-05:00,XTLB,neutral
1395513.0,54 Biggest Movers From Yesterday,2019-01-24 05:04:00-05:00,XTLB,neutral
1395514.0,40 Stocks Moving In Wednesday's Mid-Day Session,2019-01-23 12:27:00-05:00,XTLB,neutral
1395515.0,50 Biggest Movers From Yesterday,2018-12-18 06:11:00-05:00,XTLB,neutral
1395516.0,70 Biggest Movers From Yesterday,2018-11-13 04:46:00-05:00,XTLB,neutral
1395517.0,54 Stocks Moving In Monday's Mid-Day Session,2018-11-12 12:38:00-05:00,XTLB,neutral
1395518.0,25 Stocks Moving In Monday's Pre-Market Session,2018-11-12 08:18:00-05:00,XTLB,neutral
1395519.0,"XTL Biopharmaceuticals shares spike up 23.9% after an 8-K showed the company has light exposure Canndoc, a producer of pharma grade cannabis products; The company has a low number of shares outstanding and price action may be related to low-float action.",2018-11-08 14:00:00-05:00,XTLB,positive
1395520.0,"XTL Biopharmaceuticals 8-K Shows Co.'s Investment, Intercure, Recently Purchased Canndoc Which Puts It In The Cannabis Space; BZ NOTE: Co. Only Holds 2.5% Stake In Intercure",2018-11-08 13:56:00-05:00,XTLB,positive
1395521.0,XTL Biopharmaceuticals Q3 EPS $0.004 Up From $(0.002) YoY,2018-11-01 10:10:00-04:00,XTLB,neutral
1395522.0,36 Stocks Moving In Wednesday's Mid-Day Session,2018-10-17 12:49:00-04:00,XTLB,neutral
1395523.0,31 Stocks Moving In Wednesday's Pre-Market Session,2018-10-17 08:06:00-04:00,XTLB,neutral
1395524.0,42 Biggest Movers From Yesterday,2018-10-16 05:27:00-04:00,XTLB,neutral
1395525.0,35 Stocks Moving In Monday's Mid-Day Session,2018-10-15 12:47:00-04:00,XTLB,neutral
1395526.0,22 Stocks Moving In Monday's Pre-Market Session,2018-10-15 08:07:00-04:00,XTLB,neutral
1395527.0,48 Biggest Movers From Yesterday,2018-06-20 03:55:00-04:00,XTLB,neutral
1395528.0,38 Stocks Moving In Tuesday's Mid-Day Session,2018-06-19 13:44:00-04:00,XTLB,neutral
1395529.0,XTL Biopharmaceuticals Reports Q1 Adj. EPS $(0.002) vs $(0.003) In Same Qtr. Last Year,2018-05-29 17:38:00-04:00,XTLB,neutral
1395530.0,40 Stocks Moving In Wednesday's Mid-Day Session,2018-05-16 12:39:00-04:00,XTLB,neutral
1395531.0,26 Stocks Moving In Wednesday's Pre-Market Session,2018-05-16 08:14:00-04:00,XTLB,neutral
1395532.0,"Benzinga's Biggest Movers For The Week Of May 7, 2018",2018-05-11 16:01:00-04:00,XTLB,neutral
1395533.0,53 Biggest Movers From Yesterday,2018-05-09 05:37:00-04:00,XTLB,neutral
1395534.0,36 Stocks Moving In Tuesday's Mid-Day Session,2018-05-08 14:26:00-04:00,XTLB,neutral
1395535.0,"Benzinga's Daily Biotech Pulse: Karyopharm's STORM Study, Inogen Rallies On Earnings",2018-05-01 07:51:00-04:00,XTLB,neutral
1395536.0,26 Stocks Moving In Thursday's Pre-Market Session,2018-02-08 08:03:00-05:00,XTLB,neutral
1395537.0,28 Stocks Moving In Tuesday's Pre-Market Session,2018-01-23 08:02:00-05:00,XTLB,neutral
1395538.0,26 Stocks Moving In Thursday's Pre-Market Session,2018-01-18 08:08:00-05:00,XTLB,neutral
1395539.0,XTL Biopharmaceuticals Ltd. Regains Compliance with Nasdaq's Minimum Stockholders' Equity Listing Requirements,2017-12-06 12:10:00-05:00,XTLB,neutral
1395540.0,"XTL Biopharma 6-K Filing Shows Co. Received Letter From Nasdaq Listing Qualifications Dept. Indicating Co. Failed To Comply With $35M Market Value, $2.5M Shareholder Equity Requirements Oct. 17",2017-10-23 11:10:00-04:00,XTLB,negative
1395541.0,XTL Biopharma Reports 1H'17 Results: EPS $(0.006) vs $(0.004) In 1H'16,2017-09-26 09:27:00-04:00,XTLB,neutral
1395542.0,XTL Biopharmaceuticals Reports Q1 EPS $(0.00) vs $(0.00) In Prior Year Period,2017-06-15 09:39:00-04:00,XTLB,neutral
1395543.0,"XTL Biopharmaceuticals Unveils hCDR1 Preclinical Data for the Treatment of Sj√∂gren's Syndrome, Co. Says Statistically Significant Effect",2017-04-05 09:11:00-04:00,XTLB,positive
1395544.0,XTL Biopharmaceuticals Reports FY16 EPS $(0.00) vs. $(0.01) YoY,2017-03-30 08:56:00-04:00,XTLB,neutral
1395545.0,25 Stocks Moving In Tuesday's Pre-Market Session,2017-03-28 08:28:00-04:00,XTLB,neutral
1395546.0,15 Biggest Mid-Day Gainers For Thursday,2017-03-09 12:32:00-05:00,XTLB,neutral
1395547.0,Shares of XTL Biopharma Are Trading Higher Premarket Up 14.9% At $2.61/Share,2017-03-09 08:52:00-05:00,XTLB,positive
1395548.0,22 Stocks Moving In Thursday's Pre-Market Session,2017-03-09 08:29:00-05:00,XTLB,neutral
1395549.0,18 Biggest Mid-Day Gainers For Wednesday,2017-03-08 12:58:00-05:00,XTLB,neutral
1395550.0,22 Stocks Moving In Wednesday's Pre-Market Session,2017-03-08 08:12:00-05:00,XTLB,neutral
1395551.0,XTL Biopharma Announces Private Placement of 1.4M ADS's at $2.00/ADS,2017-03-07 12:43:00-05:00,XTLB,neutral
1395552.0,Mid-Afternoon Market Update: Monotype Drops On Earnings Miss; LMI Aerospace Shares Spike Higher,2017-02-17 14:35:00-05:00,XTLB,positive
1395553.0,18 Biggest Mid-Day Losers For Friday,2017-02-17 13:08:00-05:00,XTLB,negative
1395554.0,Mid-Day Market Update: Arista Networks Surges After Strong Results; Nu Skin Shares Slide,2017-02-17 12:30:00-05:00,XTLB,positive
1395555.0,Mid-Morning Market Update: Markets Open Lower; Deere Profit Tops Estimates,2017-02-17 10:00:00-05:00,XTLB,positive
1395556.0,XTL Biopharma Reports $2.5M Registered Direct Offering,2017-02-17 08:01:00-05:00,XTLB,neutral
1395557.0,18 Biggest Mid-Day Gainers For Thursday,2017-02-16 12:30:00-05:00,XTLB,neutral
1395558.0,25 Stocks Moving In Thursday's Pre-Market Session,2017-02-16 08:17:00-05:00,XTLB,neutral
1395559.0,X T L Biopharma +20.36% Premarket @$3.70,2017-02-16 04:58:00-05:00,XTLB,neutral
1395560.0,Mid-Afternoon Market Update: Dow Rises 150 Points; Zeltiq Aesthetics Shares Surge Following Acquisition News,2017-02-13 14:58:00-05:00,XTLB,positive
1395561.0,10 Biggest Mid-Day Losers For Monday,2017-02-13 13:22:00-05:00,XTLB,negative
1395562.0,Mid-Day Market Update: Crude Oil Down Around 2%; Zosano Pharma Shares Spike Higher,2017-02-13 12:00:00-05:00,XTLB,negative
1395563.0,XTL Biopharma Reports Q2 EPS $(0.002) vs $(0.001) in Same Qtr. Last Year,2016-09-27 08:33:00-04:00,XTLB,neutral
1395564.0,XTL Biopharma Reports European Patent Office Issued Patent for hCDR1,2016-09-07 08:38:00-04:00,XTLB,neutral
1395565.0,XTL Biopharmaceuticals Announces the European Patent Office has Issued a Patent for its Lupus Drug hCDR1,2016-09-07 08:33:00-04:00,XTLB,neutral
1395566.0,XTL Biopharmaceuticals Announces New Patent Filing in U.S. for Lupus Drug hCDR1,2016-08-11 09:01:00-04:00,XTLB,neutral
1395567.0,XTL Biopharmaceuticals Completes Phase 2 Trial Design for Lead Compound hCDR1 in the Treatment of Lupus,2016-03-21 08:31:00-04:00,XTLB,neutral
1395568.0,"XTL Biopharmaceuticals Receives European Medicines Agency's SME Status,  Company Sees Phase 2 Trial For hCDR1 To Begin In 2016",2016-02-22 09:04:00-05:00,XTLB,neutral
1395569.0,"XTL Biopharmaceuticals' Lupus Drug hCDR1 Granted Patent for Pharmaceutical Composition & Manufacturing Processes, Expects To Initiate Phase 2 Trial Of hCDR1",2016-02-10 08:32:00-05:00,XTLB,positive
1395570.0,XTL Biopharmaceuticals' Lupus Drug hCDR1 Granted Patent for Pharmaceutical Composition & Manufacturing Processes,2016-02-10 08:31:00-05:00,XTLB,positive
1395571.0,XTL Biopharma Reports Positive Feedback From FDA On IND Filing For hCDR1 Lupus Drug,2016-01-25 08:31:00-05:00,XTLB,positive
1395572.0,XTL Biopharmaceuticals Gives Protocol to Yeda for Advanced Clinical Trial of hCDR1 in the Treatment of Lupus,2016-01-11 08:32:00-05:00,XTLB,positive
1395573.0,"Mid-Morning Market Update: Markets Open Lower; Tesla Motors Delivers 17,400 Vehicles in Fourth Quarter",2016-01-04 10:10:00-05:00,XTLB,negative
1395574.0,HC Wainwright on XTL Biopharma: Reiterates Buy as 'Phase 2 Lupus Study On Track for 2016',2015-12-02 07:09:00-05:00,XTLB,neutral
1395575.0,XTL Biopharmaceuticals Reports Q3 EPS ($0.002) vs. Prior Year Quarter ($0.011),2015-12-01 08:35:00-05:00,XTLB,neutral
1395576.0,XTL Biopharmaceuticals Reports Agreement With Yeda Research and Development Company Ltd. to Amend License Agreement for Lupus Asset,2015-10-13 08:46:00-04:00,XTLB,positive
1395577.0,"Mid-Day Market Update: Wednesday's Movers, US Rebounds, China And More",2015-08-26 12:47:00-04:00,XTLB,neutral
1395578.0,Morning Market Losers,2015-08-26 09:52:00-04:00,XTLB,negative
1395579.0,Benzinga's Top Initiations,2015-05-08 10:53:00-04:00,XTLB,positive
1395580.0,"XTL Biopharmaceuticals Aims To Tame Lupus, HC Wainwright Initiates At Buy",2015-05-08 09:35:00-04:00,XTLB,neutral
1395581.0,H.C Wainwright Initiates X T L Biopharmaceuticals With Buy,2015-05-08 09:12:00-04:00,XTLB,neutral
1395582.0,"H.C Wainwright Initiates Coverage on XTL Biopharmaceuticals at Buy, Announces $6.00 PT",2015-05-08 07:18:00-04:00,XTLB,neutral
1395583.0,"HC Wainwright Initiates Coverage on XTL Biopharmaceuticals at Buy, Announces $6.00 PT",2015-05-08 07:18:00-04:00,XTLB,neutral
1395584.0,Hearing Unconfimred Market Chatter XTLB Possible Teva Takeover Target,2015-02-25 09:36:00-05:00,XTLB,neutral
1395585.0,Biotech Investor Alex Rabinovich Increases Stake in XTL Biopharmaceuticals To 51%,2015-02-17 08:41:00-05:00,XTLB,neutral
1395586.0,Morning Market Movers ,2014-01-08 09:58:00-05:00,XTLB,neutral
1395587.0,XTL Biopharmaceuticals Sign License Agreement with Yeda Research to Develop hCDR1 Treatment for SLE,2014-01-08 08:05:00-05:00,XTLB,positive
1395588.0,Morning Market Losers ,2013-12-26 10:17:00-05:00,XTLB,negative
1395589.0,Morning Market Losers ,2013-12-16 10:10:00-05:00,XTLB,negative
1395590.0,Stocks Hitting 52-Week Lows,2013-12-12 10:19:00-05:00,XTLB,negative
1395591.0,Morning Market Losers ,2013-12-12 09:59:00-05:00,XTLB,negative
1395592.0,Morning Market Losers ,2013-12-09 10:06:00-05:00,XTLB,negative
1395593.0,Stocks Hitting 52-Week Lows,2013-09-18 10:11:00-04:00,XTLB,negative
1395594.0,XTL Biopharmaceuticals' ADRs Commence Trading on NASDAQ,2013-07-15 13:52:00-04:00,XTLB,neutral
1395595.0,FDA Grants Orphan Drug Designation for XTL's rHuEPO Treatment for Multiple Myeloma,2011-06-01 08:08:00-04:00,XTLB,positive
